Literature DB >> 33466149

KCNQ1 G219E and TRPM4 T160M polymorphisms are involved in the pathogenesis of long QT syndrome: A case report.

Yang Zhao1,2, Min Feng1, Lu-Xiang Shang1, Hua-Xin Sun1, Xian-Hui Zhou1, Yan-Mei Lu1, Ling Zhang1, Qiang Xing1, Yao-Dong Li1, Bao-Peng Tang1.   

Abstract

RATIONALE: Long QT syndrome (LQTS) is an inheritable disease characterized by prolonged QT interval on the electrocardiogram. The pathogenesis of LQTS is related to mutations in LQTS-susceptible genes encoding cardiac ion channel proteins or subunits. PATIENT CONCERNS: Here, we reported a 37-year-old female Uygur patient with palpitation and loss of consciousness. DIAGNOSES: At the time of admission, a 12-lead electrocardiogram showed a QTc interval of 514 ms. Genetic analysis revealed KCNQ1 G219E and TRPM4 T160M mutations.
INTERVENTIONS: Although beta-blockers remain the mainstay in treating LQTS, the patient underwent implantation of an automatic cardioverter defibrillator due to life-threatening arrhythmias. OUTCOMES: To explore the effect of the calcium ion antagonist verapamil on ion channels, we generated human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) from the peripheral blood mononuclear cells of the patient. The changes of action potential duration in response to verapamil were observed. LESSONS: Our results showed that patient-derived hiPSC-CMs could recapitulate the electrophysiological features of LQTS and display pharmaceutical responses to verapamil.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33466149      PMCID: PMC7808457          DOI: 10.1097/MD.0000000000024032

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  18 in total

Review 1.  Genotype- and phenotype-guided management of congenital long QT syndrome.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Curr Probl Cardiol       Date:  2013-10       Impact factor: 5.200

2.  Regulation of the Ca2+ sensitivity of the nonselective cation channel TRPM4.

Authors:  Bernd Nilius; Jean Prenen; Jisen Tang; Chunbo Wang; Grzegorz Owsianik; Annelies Janssens; Thomas Voets; Michael X Zhu
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

3.  TRPM4 controls insulin secretion in pancreatic beta-cells.

Authors:  Henrique Cheng; Andreas Beck; Pierre Launay; Stefan A Gross; Alexander J Stokes; Jean-Pierre Kinet; Andrea Fleig; Reinhold Penner
Journal:  Cell Calcium       Date:  2006-06-27       Impact factor: 6.817

4.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

Authors:  Alessandra Moretti; Milena Bellin; Andrea Welling; Christian Billy Jung; Jason T Lam; Lorenz Bott-Flügel; Tatjana Dorn; Alexander Goedel; Christian Höhnke; Franz Hofmann; Melchior Seyfarth; Daniel Sinnecker; Albert Schömig; Karl-Ludwig Laugwitz
Journal:  N Engl J Med       Date:  2010-07-21       Impact factor: 91.245

5.  Novel gene and mutation discovery in congenital long QT syndrome: let's keep looking where the street lamp standeth.

Authors:  David J Tester; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2008-07-03       Impact factor: 6.343

6.  Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.

Authors:  Miao Zhang; Cristina D'Aniello; Arie O Verkerk; Eva Wrobel; Stefan Frank; Dorien Ward-van Oostwaard; Ilaria Piccini; Christian Freund; Jyoti Rao; Guiscard Seebohm; Douwe E Atsma; Eric Schulze-Bahr; Christine L Mummery; Boris Greber; Milena Bellin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

7.  Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations.

Authors:  Marie Demion; Jérôme Thireau; Mélanie Gueffier; Amanda Finan; Ziad Khoueiry; Cécile Cassan; Nicolas Serafini; Franck Aimond; Mathieu Granier; Jean-Luc Pasquié; Pierre Launay; Sylvain Richard
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

8.  Four TRPM4 Cation Channel Mutations Found in Cardiac Conduction Diseases Lead to Altered Protein Stability.

Authors:  Beatrice Bianchi; Lijo Cherian Ozhathil; Argelia Medeiros-Domingo; Michael H Gollob; Hugues Abriel
Journal:  Front Physiol       Date:  2018-03-08       Impact factor: 4.566

9.  Identification of Genetic Alterations, as Causative Genetic Defects in Long QT Syndrome, Using Next Generation Sequencing Technology.

Authors:  Oscar Campuzano; Georgia Sarquella-Brugada; Irene Mademont-Soler; Catarina Allegue; Sergi Cesar; Carles Ferrer-Costa; Monica Coll; Jesus Mates; Anna Iglesias; Josep Brugada; Ramon Brugada
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

10.  Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.

Authors:  Daniela Malan; Miao Zhang; Birgit Stallmeyer; Jovanca Müller; Bernd K Fleischmann; Eric Schulze-Bahr; Philipp Sasse; Boris Greber
Journal:  Basic Res Cardiol       Date:  2016-01-23       Impact factor: 17.165

View more
  1 in total

Review 1.  Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 2: TRPM4 in Health and Disease.

Authors:  Csaba Dienes; Zsigmond Máté Kovács; Tamás Hézső; János Almássy; János Magyar; Tamás Bányász; Péter P Nánási; Balázs Horváth; Norbert Szentandrássy
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.